COMP <GO>
APH vs NVDA // ALTMAN Z-SCORE & DEBT/EQUITY
Amphenol Corporation (NYSE) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: APH 3
— NVDA 11
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: NVDA
LAST: $82.08 (+1.38%) • MKT CAP: $202.41B
balance-sheet
7.34
LAST: $213.66 (-0.80%) • MKT CAP: $5.15T
balance-sheet
19.52
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APH VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APH | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.90% | 74.67% | -37.77 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.60% | 65.06% | -36.46 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.9x | 23.2x | +6.69 | NVDA | /valuation <GO> |
| Free Cash Flow Yield | 2.16% | 2.58% | -0.42 | NVDA | /fcf-yield <GO> |
| Operating Margin | 25.40% | 65.21% | -39.81 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 18.50% | 63.66% | -45.16 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 51.70% | 83.38% | -31.68 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.40% | 0.02% | +0.38 | APH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 7.34 | 19.52 | -12.18 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | APH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 51.1 | +1.40 | APH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.23 | 2.04 | -0.81 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.8x | 17.0x | +22.78 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $202.41B | $5.15T | -$4.95T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APH REV | NVDA REV | APH GROSS % | NVDA GROSS % | APH FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $23.09B | $130.50B | 36.9% | 75.0% | $4.38B | $60.85B |
| FY 2024 | $15.22B | $60.92B | 33.8% | 72.7% | $2.15B | $27.02B |
| FY 2023 | $12.55B | $26.97B | — | 56.9% | $1.96B | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APH // BETA 1.23
NVDA // BETA 2.04